Human anti-KLH antibody tests

History of assay achievements
A major research focus within the Radboud University Medical Centre is on immune-regulation and immunotherapy.
For monitoring of KLH-containing cancer vaccines we recently developed the first quantitative-assay to detect human anti-KLH antibodies in serum/plasma (Aarntzen et al. CII 2012).
In recently published articles we describe our ELISA method and diverse applications of anti-KLH analysis in clinical trials: 


Title article


Targeting CD4+ T helper cells improves the induction of anti-tumor responses in dendrtitic cell based vaccination

Aarntzen et al. Cancer Res. 2013

Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-baed vaccination in metastatic melanoma

Aarntzen et al. Cancer Res. 2012

Vaccination with mRNA-eclectroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients

Aarntzen et al. Clin Cancer Res. 2011

Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccine parameters.

Aarntzen et al. CII 2012

Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxythymedine PET imaging

Aarntzen et al. PNAS 2011

Route of administation modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients

Lesterhuis et al. Clin. Cancer Res. 2011